首页> 外文期刊>Quarterly Journal of Medicine >Idiopathic pulmonary fibrosis: an update
【24h】

Idiopathic pulmonary fibrosis: an update

机译:特发性肺纤维化:最新进展

获取原文
获取原文并翻译 | 示例
       

摘要

Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition of uncertain aetiology that should be considered in the differential diagnosis of patients who experience breathlessness, cough and reduced exercise tolerance. IPF is characterized histologically by the presence of usual interstitial pneumonia, and often has typical radiological appearances. Long-term successful management options are limited and frequently unsuccessful; as the disease progresses, palliation of symptoms becomes the mainstay of treatment. In a minority of patients, lung transplantation provides the only hope of long-term survival. The median survival of patients with IPF is approximately 3 years, which in turn emphasizes the need for further investigation into its pathogenesis and potential disease-modifying pharmacological therapies.
机译:特发性肺纤维化(IPF)是病因不明的慢性肺部疾病,在进行呼吸困难,咳嗽和运动耐量降低的患者的鉴别诊断中应考虑到这一点。 IPF的组织学特征是通常存在间质性肺炎,并且通常具有典型的放射学表现。长期成功的管理选择是有限的,并且通常是不成功的;随着疾病的进展,减轻症状成为治疗的主要手段。在少数患者中,肺移植提供了长期生存的唯一希望。 IPF患者的中位生存期约为3年,这反过来又强调了需要进一步研究其发病机理和可能改变疾病的药理疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号